Chang Crystal, Gupta Ashish O, Orchard Paul J, Nascene David R, Kierstein Janell, Tryon Rebecca K, Lund Troy C
Division of Pediatric Blood and Marrow Transplantation and Cellular Therapy Program, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota.
Department of Radiology, University of Minnesota Medical School, Minneapolis, Minnesota.
F S Rep. 2022 Dec 23;4(1):24-28. doi: 10.1016/j.xfre.2022.12.005. eCollection 2023 Mar.
To report 3 cases of adrenoleukodystrophy (ALD) in children conceived by in vitro fertilization (IVF) and egg donation.
A case report.
Patients aged 4-5 years old, evaluated by the University of Minnesota Leukodystrophy Center, who were diagnosed with ALD after being conceived by IVF with oocytes provided by the same donor.
One patient received a hematopoietic stem cell transplant from a human leukocyte antigen-matched donor, and 1 patient received autologous lentiviral corrected hematopoietic cells. The disease state in 1 patient was unfortunately too advanced for effective treatment to be administered.
Progression of disease after diagnosis or treatment was observed by cerebral magnetic resonance imaging and monitoring the development or advancement of any cognitive, adaptive, and motor deficits.
Patients who received a transplant for ALD successfully experienced little to no disease progression at least 6 months to 1 year after treatment.
These 3 cases of transmission of ALD through oocyte donation and IVF highlight the potential need to implement more comprehensive genetic screening of gamete donors to prevent the transfer of rare but severe genetic diseases through IVF. Further, these cases highlight limitations in carrier screening guidelines that limit reportable variants to pathogenic and likely pathogenic variants.
报告3例通过体外受精(IVF)和卵子捐赠受孕的儿童肾上腺脑白质营养不良(ALD)病例。
病例报告。
年龄在4至5岁之间,由明尼苏达大学脑白质营养不良中心评估,通过IVF使用同一供体提供的卵母细胞受孕后被诊断为ALD的患者。
1例患者接受了来自人类白细胞抗原匹配供体的造血干细胞移植,1例患者接受了自体慢病毒校正的造血细胞。不幸的是,1例患者的疾病状态已发展到晚期,无法进行有效治疗。
通过脑磁共振成像观察诊断或治疗后疾病的进展情况,并监测任何认知、适应性和运动功能缺陷的发展或进展。
接受ALD移植的患者在治疗后至少6个月至1年成功经历了极少或无疾病进展。
这3例通过卵子捐赠和IVF传播ALD的病例凸显了对配子供体实施更全面基因筛查的潜在必要性,以防止通过IVF传播罕见但严重的遗传疾病。此外,这些病例凸显了携带者筛查指南的局限性,该指南将可报告变异限制为致病性和可能致病性变异。